Keywords: upturn, fund, assets, bil, biotechnology, investments, limited
Upturn In Fund Assets At BIL
Article | 07 August 1995
Biotechnology Investments Limited, a Guernsey-based firm that invests in the biotechnology sector, realised net gains of $10.2 million in the year ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
